| PRODUCT DESCRIPTION |
| OMEPRAZOLE PELLETS 7.5% |
| RISPERIDONE BP/PHARM EUR |
| CHEMICAL - SAMPLE OF- PYRIDINE DERIVATIVES(4 CMPDS) - (DTLS AS PER INV) - WE INTEND TO CLAIM REWARDS UNDER MEIS |
| JUBITHIONE ZPT 50 ZINC PYRITHIONE(50% FINE PARTICLE SUSPENSION) |
| JUBITHIONE ZPT 40 ZINC PYRITHIONE(40% FINE PARTICLE SUSPENSION) |
| CETYL PYRIDINIUM CHLORIDE(BP/EP/USP) |
| CHEMICAL - PYRROLIDINE DERIVATIVE - (DTLS AS PER INV) - WE INTEND TO CLAIM REWARDS UNDER MEIS |
| CHEMICAL - AZETIDINE DERIVATIVE - (DTLSAS PER INV) - WE INTEND TO CLAIM REWARDSUNDER MEIS |
| CHEMICAL - PYRROLIDINE DERIVATIVE - (DTLS AS PER INV) - WE INTEND TO CLAIM REWARDS UNDER MEIS |
| CHEMICAL - AZETIDINE DERIVATIVE - (DTLSAS PER INV) - WE INTEND TO CLAIM REWARDSUNDER MEIS |
| SYNTHESIZED/ORGANIC COMPUNDSN-((4-AMINOPHENYL)SULFONYL)-4-METHYL-2-(P-TOLYL)THIAZOLE-5-CARBOXAMIDE |
| SYNTHESIZED/ORGANIC COMPUNDSN-((4-AMINOPHENYL)SULFONYL)-4-METHYL-2-(P-TOLYL)THIAZOLE-5-CARBOXAMIDE |
| ATORVASTATIN IMPURITY B(NET QTY: 2500 MG) |
| PIRFENIDONE (MEIS APPENDIX 3B SL NO: 1124 & COUNTRY SL NO: 26 IN GROUP A) |
| SILDENAFIL CITRATE USP |
| 2-AMINOTEREPHTHALIC ACIDPRODUCT CODE 27803CAS NUMBER 10312-55-7 |
| ESOMEPRAZOLE MAGNESIUM TRIHYDRATE 22.5 PERCENT (GROUP:C,SRL NO:1124 |
| AMLODIPINE BESILATE JP (GROUP-B,SRL NO:1124 |
| LANSOPRAZOLE PELLETS 8.5% |
| BROMPHENIRAMINE MALEATE USP |
| BETAHISTINE DIHYDROCHLORIDE EP |
| OMEPRAZOLE PELLETTS 8.5% PCT W/W (PHARMACEUTICAL RAW MATERIALS) |
| CETYL PYRIDINIUM CHLORIDE BP/EP/USP -(OTHER CMPNDS CNTNG AN UNFUSED PYRDN RING (W/N HYDRGNTD) IN STRUCTURE - WE INTEND |
| AZACYCLONOL (OTHER CMPNDS CNTNG AN UNFUSED PYRDN RING (W/N HYDRGNTD) IN STRUCTURE - WE INTEND TO CLAIM REWARDS UNDER |
| HETERCYCLIC COMPOUNDS |
| FLUCONAZOLE - USP |
| AMLODIPINE BESYLATE |
| (2S)-2-HYDROXY-2-PHENYL ACETIC ACID;(1R)-1-[(4-MEHOXYPHENYL)METHYL]-1,2,3,4,5,6,7,8-OCTAHYDRO ISOQUINOLINE |
| SILDENAFIL CITRATE USP |
| OMEPRAZOLE PELLETS -8.5%(APPENDIX-3B, GROUP-B, SL.NO:59)(MEIS SL NO.1124) |
| AMLODIPINE BESYLATE PH.EUR (GROUP:B,SRLNO:1124 |
| RANITIDINE HYDROCHLORIDE EP(MEIS SERIALNO: 1124 GROUP: C) |
| ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USP (PHARMACEUTICAL RAW MATERIALS) |
| RABEPRAZOLE SODIUM (PHARMACEUTICAL RAW MATERIALS) |
| (3S,10R,13R,17S)-10,13-DIMETHYL-17-(6-METHYLHEPTAN-2-YL)2,3,4,7,8,89,10,11,12,143,14,15,16,17-TETRADECAHYDRO-1H- |
| METHYL-4-(4-METHOXY-PHENYL)2,4-DIOXOBUTYRATE) |
| SILDENAFIL CITRATE USP |
| AMLODIPINE BESYLATE USP (GROUP:B,SRL NO:1124 |
| GABAPENTIN |
| TERBINAFINE HYDROCHLORIDE BP |
| PANTOPRAZOLE SODIUM SESQUIHYDRATE USP-39GROUP-C /SRL NO:1124 |
| BOC-2-AMINO-4-THIAZOLECARBOXYLIC ACID 98% |
| FREE SAPLE NCV ZINC PYRITHIONE 48 % |
| TAMSULOSIN HYDROCHLORIDE SUSTAIN RELEASE0.1% W/W PELLETS |
| JUBITHIONE ZPT-50(ZINC PYRITHIONE 50% FPS) |
| OMEPRAZOLE PELLETS 8.5%(APPENDIX -3B, GROUP-B,SL.NO.1)(MEIS SL NO.1124) |
| OMEPRAZOLE PELLETS 8.5% |
| DONEPEZIL HCL USP 39 (GROUP:B,SRL NO:1124 |
| ETORICOXIB RELATED COMPOUND - 02 (GROUP:B,SRL NO:1124 |
| MONTELUKAST SODIUM,CONTROL NO.6174916516,MFG.AUGUST/2016,RE TEST DATE:JULY/2019 |